semaglutide

weight loss scale weigh measure tape obesity overweight

Lilly rounds out orforglipron data ahead of obesity filings

With a complete weight loss data set in hand, Lilly is eyeing regulatory filings for orforglipron and thinks approvals could start arriving next year.

Fraiser Kansteiner Sep 17, 2025 9:00am

head to head against clash football helmets fight combat

BrightGene tops Novo drug in diabetes ahead of Zepbound showdown

Jun 23, 2025 2:30pm

Lilly's oral GLP-1 delivers Ozempic-like efficacy in phase 3

Apr 17, 2025 6:45am

Novo links CagriSema to 16% weight loss, sending stock down

Mar 10, 2025 9:30am

Novo stock crashes after CagriSema misses weight-loss goal

Dec 20, 2024 8:15am

Macrocyclic peptides preserve muscle in mice given semaglutide

Dec 12, 2024 12:45pm